JeanMarie Guenot, Ph.D. in pharmaceutical and biotechnology industry with 20 years experience. President and CEO of Amphivena Therapeutics, Inc. which develops antibody therapies for hematologic malignancies. Also she founded SKS Ocular. Dr. Guenot’s management experience in oncology, cardiovascular disease, neurology and ophthalmic diseases. JeanMarie Guenot’s scientific career as a scientist in Preclinical R&D.
Trained in physical and medical chemistry receiving a award in BioBusiness Network’s Innovative Bio-Partnering. Dr. Jeanmarie Guenot currently a Pharmaceutical Business Executive. She has served as a business advisor for Hoffman-La Roche. She focused on semi-empirical and quantum mechanical methods for drug design and nuclear magnetic.
The co-founder of Maverick Therapeutics, a biotechnology company. JeanMarie Guenot an entrepreneur with over two decades of experience she’s an expert at her work. Dr. Guenot worked with both private and public, in different stages of the business lifecycle. She has worked in the research and development department of various pharmaceutical companies. Dr. Jeanmarie Guenot develops immunotherapies for cancer treatment at Amphivena Therapeutics. She has excellent leadership skills that has influenced her company to make remarkable progress. Dr. Guenot has expert knowledge when it comes to helping cancer patients fight cancer according to amphivena.com. She led the Biogen Idec-PDL Alliance and was a member of the Joint Steering Committee.